Stockscreener 앱 받기
0.0575
42.50%
-0.0425
시간 외 거래:
.06
0.0025
+4.35%
Vincerx Pharma Inc 주식(VINC)의 최신 뉴스
Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com
Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX
Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com
Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister
Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga
The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com
VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa
VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India
Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa
Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView
Vincerx Pharma announces plan to delist from Nasdaq - TipRanks
Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire
Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World
vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia
vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India
Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks
VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa
VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga
Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada
Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals
Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks
Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times
Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com
Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener
Failed Merger Forces Vincerx Pharma to Begin Company Wind-Down: What's Next for Investors? - Stock Titan
VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com
VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline By Investing.com - Investing.com South Africa
Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World
Vincerx Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Vincerx Pharma Inc expected to post a loss of $3.40 a shareEarnings Preview - TradingView
Such Is The Power Of Vincerx Pharma Inc (NASDAQ: VINC) - Stocks Register
Vincerx Pharma plans reverse merger with QumulusAI By Investing.com - Investing.com Australia
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewswire
VINC stock touches 52-week low at $0.73 amid sharp annual decline - Investing.com UK
Vincerx Pharma Plans Reverse Merger With AI Infrastructure Firm QumulusAI -March 18, 2025 at 09:40 am EDT - Marketscreener.com
Vincerx Pharma plans reverse merger with QumulusAI - Investing.com India
0.24%
36.06%
자본화:
|
볼륨(24시간):